MedTrace Logo

Effectiveness of Vaporous Hyperoxia Therapy (VHT) in the Treatment of Chronic Diabetic Foot Ulcers

NCT04210609 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-10-11

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness of Vaporous Hyperoxia Therapy (VHT) for the treatment of Diabetic Foot Ulcers.

Conditions

  • Diabetic Foot Ulcer

Interventions

DEVICE

Vaporous Hyperoxia Therapy

55 minutes of treatment, 2 times per week

Sponsors & Collaborators

  • Vaporox

    lead INDUSTRY

Principal Investigators

  • Dustin Kruse, DPM · Rocky Mountain Foot and Ankle Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-04
Primary Completion
2022-10-03
Completion
2022-10-03
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04210609 on ClinicalTrials.gov